{"id":4462,"count":2,"description":"Hyperthyroidism (overactive thyroid) most commonly caused by Graves' disease (autoimmune TSH-receptor antibody-mediated), toxic multinodular goitre, or solitary toxic adenoma. Symptoms include weight loss with normal\/increased appetite, palpitations, tremor, heat intolerance, anxiety, frequent stools, and (in Graves') eye signs (proptosis, lid lag, ophthalmopathy). The MedsBase Overactive Thyroid Treatment catalogue carries the antithyroid thionamide drugs that block thyroid peroxidase and reduce hormone synthesis.\n\n<strong>\u0394\u03b9\u03b1\u03b8\u03ad\u03c3\u03b9\u03bc\u03b5\u03c2 \u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ad\u03c2.<\/strong> \u03a4\u03bf \u03bc\u03b5\u03b8\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7 (\u03c4\u03bf \u03c3\u03cd\u03b3\u03c7\u03c1\u03bf\u03bd\u03bf \u03c0\u03c1\u03bf\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf \u03b8\u03b5\u03b9\u03bf\u03bd\u03b1\u03bc\u03af\u03b4\u03b9\u03bf \u2014 \u03bc\u03af\u03b1 \u03c6\u03bf\u03c1\u03ac \u03c4\u03b7\u03bd \u03b7\u03bc\u03ad\u03c1\u03b1 \u03b4\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1, \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b7\u03c0\u03b1\u03c4\u03bf\u03c4\u03bf\u03be\u03b9\u03ba\u03cc \u03b1\u03c0\u03cc \u03c4\u03bf \u03c0\u03c1\u03bf\u03c0\u03c5\u03bb\u03bf\u03b8\u03b5\u03b9\u03bf\u03bf\u03c5\u03c1\u03b1\u03ba\u03af\u03bb\u03b9\u03bf \u03b5\u03ba\u03c4\u03cc\u03c2 \u03b1\u03c0\u03cc \u03c4\u03bf \u03c0\u03c1\u03ce\u03c4\u03bf \u03c4\u03c1\u03af\u03bc\u03b7\u03bd\u03bf \u03c4\u03b7\u03c2 \u03b5\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03b9\u03ba\u03ae \u03ba\u03c1\u03af\u03c3\u03b7) \u03b5\u03af\u03bd\u03b1\u03b9 \u03b4\u03b9\u03b1\u03b8\u03ad\u03c3\u03b9\u03bc\u03bf \u03c9\u03c2 <a href=\"https:\/\/medsbase.com\/el\/methimez\/\">Methimez<\/a>. \u039f \u03ba\u03b1\u03c1\u03b2\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7 (\u03c4\u03bf \u03c0\u03c1\u03bf\u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u03c4\u03bf\u03c5 \u03bc\u03b5\u03b8\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7, \u03b5\u03c5\u03c1\u03ad\u03c9\u03c2 \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bc\u03b5\u03bd\u03bf \u03c3\u03c4\u03bf \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf \u0392\u03b1\u03c3\u03af\u03bb\u03b5\u03b9\u03bf\/\u0395\u03c5\u03c1\u03ce\u03c0\u03b7\/\u0399\u03bd\u03b4\u03af\u03b1\/\u0391\u03c3\u03af\u03b1) \u03c9\u03c2 <a href=\"https:\/\/medsbase.com\/el\/neomercazole\/\">Neomercazole<\/a>.\n\n<strong>\u039f\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u03c7\u03c1\u03ae\u03c3\u03b7\u03c2.<\/strong> Initial dose for moderate Graves' disease: methimazole 15\u201330 mg daily or carbimazole 20\u201340 mg daily, titrated based on TSH and free T4 measured every 4\u20136 weeks. Most patients achieve euthyroid state within 6\u201312 weeks. Long-term options: continue antithyroid drug for 12\u201318 months (40% remission rate after stopping in Graves'), radioactive iodine ablation (definitive but causes permanent hypothyroidism), or surgical thyroidectomy. Beta-blockers (propranolol \u2014 see <a href=\"https:\/\/medsbase.com\/el\/heart-blood-pressure\/\">\u039a\u03b1\u03c1\u03b4\u03b9\u03ac &amp; \u03a0\u03af\u03b5\u03c3\u03b7 \u0391\u03af\u03bc\u03b1\u03c4\u03bf\u03c2<\/a>) \u03b3\u03b9\u03b1 \u03c3\u03c5\u03bc\u03c0\u03c4\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c0\u03b1\u03bb\u03bc\u03ce\u03bd, \u03c4\u03c1\u03cc\u03bc\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03ac\u03b3\u03c7\u03bf\u03c5\u03c2 \u03b5\u03bd\u03ce \u03b1\u03bd\u03b1\u03bc\u03ad\u03bd\u03b5\u03c4\u03b1\u03b9 \u03b7 \u03b5\u03c0\u03af\u03b4\u03c1\u03b1\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03b1\u03bd\u03c4\u03b9\u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03bf\u03cd\u03c2 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5.\n\n<strong>\u03a3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc.<\/strong> <strong>\u03a5\u03c0\u03bf\u03c7\u03c1\u03b5\u03c9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03c1\u03bf\u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03c5\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b2\u03b1\u03c3\u03b9\u03ba\u03ad\u03c2 \u03b5\u03be\u03b5\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2 FBC \u03ba\u03b1\u03b9 LFTs.<\/strong> \u03a4\u03b1 \u03b1\u03bd\u03c4\u03b9\u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03ae \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 \u03c0\u03c1\u03bf\u03ba\u03b1\u03bb\u03bf\u03cd\u03bd \u03b1\u03b3\u03ba\u03c1\u03bf\u03c0\u03b5\u03bd\u03af\u03b1 \u03c3\u03b5 0,1\u20130,5% \u03c4\u03c9\u03bd \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd (\u03c3\u03c5\u03bd\u03ae\u03b8\u03c9\u03c2 \u03b5\u03bd\u03c4\u03cc\u03c2 90 \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03bf\u03c2 \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf\u03c2 \u03bc\u03b5 \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03b7 \u03b4\u03cc\u03c3\u03b7) \u2014 \u03be\u03b1\u03c6\u03bd\u03b9\u03ba\u03cc\u03c2 \u03c0\u03c5\u03c1\u03b5\u03c4\u03cc\u03c2, \u03c0\u03bf\u03bd\u03cc\u03bb\u03b1\u03b9\u03bc\u03bf\u03c2, \u03c3\u03c4\u03bf\u03bc\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b5\u03bb\u03ba\u03ce\u03c3\u03b5\u03b9\u03c2 \u03b1\u03c0\u03b1\u03b9\u03c4\u03bf\u03cd\u03bd \u03ac\u03bc\u03b5\u03c3\u03b7 FBC \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b1\u03ba\u03bf\u03c0\u03ae \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03b5\u03ac\u03bd \u03c5\u03c0\u03ac\u03c1\u03c7\u03b5\u03b9 \u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03bf\u03c0\u03b5\u03bd\u03af\u03b1. \u0397\u03c0\u03b1\u03c4\u03bf\u03c4\u03bf\u03be\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u2014 \u03c4\u03bf \u03c0\u03c1\u03bf\u03c0\u03c5\u03bb\u03bf\u03b8\u03b5\u03b9\u03bf\u03bf\u03c5\u03c1\u03b1\u03ba\u03af\u03bb\u03b9\u03bf \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf \u03bc\u03b5\u03b8\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7\u00b7 \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03cd\u03b8\u03b7\u03c3\u03b7 LFT \u03ba\u03b1\u03c4\u03ac \u03c4\u03b9\u03c2 \u03c0\u03c1\u03ce\u03c4\u03b5\u03c2 \u03c6\u03ac\u03c3\u03b5\u03b9\u03c2 \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2. \u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7: \u03c0\u03c1\u03bf\u03c4\u03b9\u03bc\u03ac\u03c4\u03b1\u03b9 \u03c4\u03bf \u03c0\u03c1\u03bf\u03c0\u03c5\u03bb\u03bf\u03b8\u03b5\u03b9\u03bf\u03bf\u03c5\u03c1\u03b1\u03ba\u03af\u03bb\u03b9\u03bf \u03c3\u03c4\u03bf \u03c0\u03c1\u03ce\u03c4\u03bf \u03c4\u03c1\u03af\u03bc\u03b7\u03bd\u03bf (\u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03c4\u03b5\u03c1\u03b1\u03c4\u03bf\u03b3\u03cc\u03bd\u03bf \u2014 \u03bc\u03b5\u03b8\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7-\u03c0\u03c1\u03bf\u03ba\u03b1\u03bb\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b1\u03c0\u03bb\u03b1\u03c3\u03af\u03b1 \u03b4\u03ad\u03c1\u03bc\u03b1\u03c4\u03bf\u03c2 \u03ba\u03b1\u03b9 \u03c7\u03bf\u03b1\u03bd\u03b9\u03ba\u03ae \u03b1\u03c4\u03c1\u03b7\u03c3\u03af\u03b1), \u03bc\u03b5\u03c4\u03ac \u03b5\u03bd\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u03c3\u03b5 \u03bc\u03b5\u03b8\u03b9\u03bc\u03b1\u03b6\u03cc\u03bb\u03b7 \u03c3\u03c4\u03bf \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03bf \u03c4\u03c1\u03af\u03bc\u03b7\u03bd\u03bf. \u039f \u03c5\u03c0\u03bf\u03bf\u03be\u03cd\u03c2 \u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03af\u03c4\u03b9\u03b4\u03b1 \u03c0\u03b1\u03c1\u03bf\u03c5\u03c3\u03b9\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03c5\u03c0\u03b5\u03c1\u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03b9\u03c3\u03bc\u03cc \u03b1\u03bb\u03bb\u03ac \u0394\u0395\u039d \u03b1\u03bd\u03c4\u03b1\u03c0\u03bf\u03ba\u03c1\u03af\u03bd\u03b5\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b1\u03bd\u03c4\u03b9\u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03ae \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 (\u03c4\u03b1 NSAIDs \u03ba\u03b1\u03b9 \u03bf\u03b9 \u03b2-\u03b1\u03bd\u03b1\u03c3\u03c4\u03bf\u03bb\u03b5\u03af\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03ba\u03b1\u03c4\u03ac\u03bb\u03bb\u03b7\u03bb\u03bf\u03b9\u00b7 \u03b7 \u03c3\u03ac\u03c1\u03c9\u03c3\u03b7 \u03b8\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03bf\u03cd\u03c2 \u03b2\u03bf\u03b7\u03b8\u03ac \u03c3\u03c4\u03b7 \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7). \u038c\u03bb\u03b1 \u03c4\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03b1 \u03c4\u03b7\u03c2 MedsBase \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc <strong>WHO-GMP \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2<\/strong> \u03ba\u03b1\u03b9 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a>.","link":"https:\/\/medsbase.com\/el\/overactive-thyroid-treatment\/","name":"\u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b3\u03b9\u03b1 \u03a5\u03c0\u03b5\u03c1\u03b4\u03c1\u03b1\u03c3\u03c4\u03ae\u03c1\u03b9\u03bf \u0398\u03c5\u03c1\u03b5\u03bf\u03b5\u03b9\u03b4\u03ae","slug":"overactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat\/4462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product?product_cat=4462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}